multi-well-plate_imaging

Flexible Microscopy Leasing for Biopharma

Access advanced imaging systems without large upfront costs. Scale your research as your needs grow.

Why lease a microscope?

Access to advanced microscopy is essential, but large upfront costs can slow progress. Leasing offers a more flexible way to get the systems you need, when you need them. It helps you move faster, manage budgets, and keep pace with changing research demands.

  • Lower upfront costs

    Avoid large initial investments by spreading costs over time.

  • Predictable payments

    Plan your budget with consistent, fixed monthly payments.

  • Access the latest systems

    Use advanced ZEISS technology without waiting for full capital approval.

  • Scale as you grow

    Add or upgrade systems as your research needs expand.

  • Start faster

    Get up and running quickly without long procurement delays.

Transform your investment

By leasing through ZEISS, you transform your microscopy investment from a capital expenditure to an operating expense with ZEISS flexible financing options. High capital costs limit access to state-of-the-art technology, delaying innovation.

  • Predictable payments and lower upfront costs: Spread costs over time for predictable expenses, crucial for research funding cycles.
  • Access to the latest imaging technology: Upgrade to next-generation ZEISS systems for high-resolution drug discovery and biomarker analysis.
  • Preserve capital and reduce risk: Preserve capital for R&D and clinical trials while accessing advanced imaging systems.
  • Ideal for biopharma startups and growing labs: Reduce upfront investment and scale microscopy capabilities as research demands evolve.
  • Comprehensive training and support: Optimize microscopy workflows for pharmaceutical research with expert guidance.

 

*All leasing and financing requests are subject to credit approval and eligibility assessment in accordance with ZEISS financial policies.

Why Biopharma leaders choose ZEISS for imaging excellence

Empower your research and accelerate discovery with our flexible capital leasing service
  • Global leader in microscopy

    ZEISS has over a century of experience in microscopy. Leading biopharma companies trust ZEISS for high-resolution imaging that supports drug discovery and biomarker research. Our systems deliver precise results for preclinical studies, cell analysis, and molecular imaging.

  • Seamless technology upgrades

    Our leasing program gives you access to the latest imaging upgrades. You can benefit from new technology without major reinvestment. Regular upgrades help keep your research up to date with industry and regulatory changes.

  • Dedicated service & support

    Our specialists provide training, application support, and help improve your workflows. This ensures reliable, high-quality imaging for your research. With ZEISS, you gain both an imaging solution and a trusted partner in your drug discovery work.

Configure your Axioscan 7 for Spatial Biology

Workflow automation for spatial biology at scale

The new Axioscan 7 Spatial Biology Configuration is designed to maximize efficiency, accuracy, and reproducibility for multiplex immunofluorescence (mIF) and high-throughput spatial biology workflows.